Journal List > Asian Oncol Nurs > v.18(1) > 1095312

Ju, Kim, and Kim: Distress and Quality of Life in Patients with Esophageal Cancer

초록

Purpose

The purpose of this study was to identify the level of distress and quality of life (QoL) in esophageal cancer patients, and to identify the factors influencing QoL.

Methods

A sample of 103 patients who have esophageal cancer were included in a descriptive study. The instruments used were the Distress Thermometer and Problem List, and the Functional Assessment of Cancer Therapy-General (FACT-G) version 4.

Results

The mean distress score of the subjects was 4.06±2.04 out of 10. The total mean score of quality of life was 66.39±12.86 out of 108, the highest category was physical well-being with a mean item score of 21.78±5.51, the lowest was emotional well-being with a mean item score of 14.69±3.68. The levels of distress and QoL were negatively correlated (r=−.61, p<.001). Stepwise regression analysis revealed that the QoL of the patients was explained by type of treatment and distress. These variables explained 35% of the variance in QoL.

Conclusion

The QoL of patients with esophageal cancer was relatively low, and the type of treatment and distress was the most important factor affecting quality of life. Thus, to improve the QoL of patients with esophageal cancer, it is important to assess their distress and to provide appropriate interventions.

REFERENCES

1. National Cancer Information Center (KR). Esophageal cancer statistics in 2015 [Internet]. Available from. http://www.cancer.go.kr/mbs/cancer/jsp/cancer/cancer.jsp?cancerSeq=4277&menuSeq=4282&viewType=all&id=cancer_020112000000. [Accessed December 20, 2017].
2. Däster S, Soysal SD, Stoll L, Peterli R, von Flüe M, Ackermann C. Long-term quality of life after Ivor Lewis esophagectomy for esophageal cancer. World J Surg. 2014; 38:2345–51.
crossref
3. Malmström M, Ivarsson B, Johansson J, Klefsgård R. Long-term experiences after esophagectomy/gastrectomy for cancer-a focus group study. Int J Nurs Stud. 2013; 50:44–52.
4. National Cancer Information Center (KR). Recommendation for cancer screening [Internet]. Available from. http://search.cancer.go.kr/RSA/front. [Accessed October 20, 2017].
5. Chang YL, Tsai YF, Wu YC, Hsieh MJ. Factors relating to quality of life after esophagectomy for cancer patients in Taiwan. Cancer Nurs. 2014; 37:4–13.
crossref
6. National Comprehensive Cancer Network (US). NCCN clinical practice guidelines in oncology: distress management [Internet]. Available from. http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf. [Accessed October 21, 2015].
7. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001; 10:19–28.
crossref
8. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, Mc-Gregor BA, et al. Major depression after breast cancer: a review of epi-demiology and treatment. Gen Hosp Psychiatry. 2008; 30:112–26.
crossref
9. Kwon EJ, Yi M. Distress and quality of life in breast cancer survivors in Korea. Asian Oncol Nurs. 2012; 12:289–96.
crossref
10. Bultz BD, Carlson LE. Emotional distress: the sixth vital sign in cancer. J Clin Oncol. 2005; 23:6440–1.
11. Thomas BC, Bulitz BD. The future in psychosocial oncology: screening for emotional distress- the sixth vital sign. Future Oncol. 2008; 4:779–84.
12. Choi SH. Supportive nursing needs for esophageal cancer patients [dissertation]. Seoul: Ewha Womans Univ.;2013.
13. Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 1993; 11:327–36.
crossref
14. Seo JY, Yi M. Distress and quality of life in cancer patients receiving chemotherapy. Asian Oncol Nurs. 2015; 15:18–27.
crossref
15. Tonsing KN, Vungkhanching M. Assessing psychological in cancer patients: the use of distress thermometer in an outpatient cancer/hema-tology treatment center. Soc Work Health Care. 2018; 57:126–36.
16. Kang HK. Nutritional statues and quality of life in patients with esophageal cancer [dissertation]. Seoul: Chung-Ang Univ.;2012.
17. Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist. 2018; 23:97–104.
crossref
18. Kim GD, Jang HJ. Effects of pain, sleep disturbance, and fatigue on the quality of life in patients with pancreatic cancer undergoing chemotherapy. Asian Oncol Nurs. 2012; 12:117–24.
crossref
19. Yang J, Yi M. Factors influencing quality of life in thyroid cancer patients with thyroidectomy. Asian Oncol Nurs. 2015; 15:59–66.
crossref
20. Jeffe DB, Pérez M, Cole EF, Liu Y, Schootman M. The effects of surgery type and chemotherapy on early-stage breast cancer patients’ quality of life over 2-year follow-up. Ann Surg Oncol. 2016; 23:735–43.
crossref
21. Baek Y, Yi M. Factors influencing quality of life during chemotherapy for colorectal cancer patients in South Korea. J Korean Acad Nurs. 2015; 45:604–12.
crossref
22. Noordman BJ, Verdam MG, Lagarde SM, Hulshof MC, van Hagen P, van Berge Henegouwen MI, et al. Effect of neoadjuvant chemotherapy on health-related quality of life in esophageal or junctional cancer: results from the randomized CROSS trial. J Clin Oncol. 2018; 36:268–75.
23. Lee JL, Kim KS. The relationships between stigma, distress, and quality of life in patients with lung cancer. J Korean Oncol Nurs. 2011; 11:237–46.
crossref
24. Jang HJ. Information, needs, treatment-related decision conflict, and quality of life in pancreatic cancer patients [dissertation]. Seoul: Yonsei Univ.;2010.
25. Kim JH. Influencing factors on depression in stomach cancer patients receiving chemotherapy. Korean J Adult Nurs. 2012; 24:588–96.
crossref
26. Tavoli A, Mohagheghi MA, Montazeri A, Roshan A, Tavoli Z, Omidi-vari S. Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter? BMC Gastroenterol. 2007; 7:28.
crossref
27. Kvale EA, Murthy R, Taylor R, Lee JY, Nabors L. Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer. 2009; 17:793–9.
crossref
28. Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, et al. Subgroups of patients with cancer with different symptom experiences and quality of life outcomes: a cluster analysis. Oncol Nurs Fo-rum. 2006; 33:E79–89.
29. Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP. Pro-spective assessment of emotional distress, cognitive function, and life in patients with cancer treated with chemotherapy. Cancer. 2004; 101:404–11.
30. Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and metaanalysis. J Clin Oncol. 2013; 31:782–93.
crossref

Table 1.
Distress and Quality of Life according to General and Clinical Characteristics (N =103) Variables Categories n (%) Distress Quality of life
Varible Categories n(%) Distress Qualiaty of Life
M ± SD t or F p M ± SD t or F p
Gender Male 93 (90.3) 4.00 ± 1.20 -0.88 .380 66.91 ± 12.63 0.29 .208
  Female 10 (9.7) 4.60 ± 2.50     61.50 ± 14.66    
Age (year) <65 62 (60.2) 4.03 ± 2.23 -0.17 .868 66.10 ± 13.33 -0.28 .779
  ≥65 41 (39.8) 4.10 ± 1.74     66.83 ± 12.26    
Marital status Single 5 (4.9) 4.40 ± 2.70 0.38 .703 72.40 ± 6.80 0.22 .286
  Married 98 (95.1) 4.04 ± 2.02     66.08 ± 13.04    
Religion Yes 42 (40.8) 3.93 ± 2.19 0.53 .595 64.55 ± 11.50 1.21 .230
  No 61 (59.2) 4.15 ± 1.95     67.66 ± 13.68    
Education ≤ Middle school 40 (38.8) 3.53 ± 1.84 2.43 .093 68.90 ± 11.81 -1.51 .225
  High school University 45 (43.7) 18 (17.5) 4.31 ± 1.954.61 2.50     64.07 ± 13.6166.61 12.79    
  ≥ University 18 (17.5) 4.61 ± 2.50     66.61 ± 12.79    
Perceived High 4 (3.9) 3.50 ± 2.52 1.86 1.61 65.50 ± 12.76 0.02 .980
economical Moderate 95 (92.2) 4.16 ± 2.01     66.46 ± 12.69    
status Low 4 (3.9) 2.25 ± 2.06     65.50 ± 20.27    
Occupation Yes 51 (49.5) 3.82 ± 1.20 -1.16 .250 69.39 ± 12.31 2.40 .018
  No 52 (50.5) 4.29 ± 2.08     63.44 ± 12.83    
Stage of cancer I a 47 (45.6) 3.77 ± 2.04 2.46 .067 71.04 ± 10.35 6.09 <.001
  II b IIIc 24 (23.3) 28 (27.2) 3.96 ± 2.274.29 1.56     65.29 ± 10.2261.75 15.31   d< a
  III c d 28 (27.2) 4.29 ± 1.56     61.75 ± 15.31    
  IV d 4 (3.9) 6.50 ± 2.65     50.75 ± 13.96    
Time period since <6 76 (73.8) 3.91 ± 2.14 -1.26 .212 68.75 ± 12.92 3.27 <.001
diagnosis (month) ≥6 27 (26.2) 4.48 ± 1.72     59.74 ± 10.26    
Comorbidity Yes No 44 (42.7) 59 (57.3) 3.63 ± 1.964.64 2.02 -2.55 .012 68.32 ± 12.0363.80 13.61 0.43 .077
  No 59 (57.3) 4.64 ± 2.02     63.80 ± 13.61    
Type of treatment CCRT 44 (42.7) 4.57 ± 1.83 2.23 .028 60.84 ± 14.14 0.16 <.001
  Planned surgery 59 (57.3) 3.68 ± 2.12     70.53 ± 10.10    

CCRT= Combined chemotherapy and radiation therapy.

Table 2.
Level of Distress, Problem List of Distress and Quality of Life (N =103)
Variables Categories n (%) M ± SD Range (min~max) Range of scale
Distress     4.06 ± 2.04 0~10 0~10
  <4 43 (41.7) 2.16 ± 0.95    
  ≥4 60 (58.3) 5.42 ± 1.44     
Problem list of dis- Emotional problem   32.83 ± 23.42    
tress (n=60) Physical problem   12.63 ± 10.93    
  Spiritual/religious concern   0.00 ± 0.00    
  Family problem   4.75 ± 4.57    
  Practical problem   23.33 ± 22.62    
Quality of life     66.39 ± 12.86 31~105 0~108
  Physical well-being   21.78 ± 5.51 2~28 0~28
  Social/family well-being   14.71 ± 3.38 8~28 0~28
  Emotional well-being   14.69 ± 3.68 5~24 0~24
  Functional well-being   15.21 ± 4.66 3~28 0~28
Table 3.
Correlations between Distre and quality of life (N=103)
Variables Distress
r (p)
Quality of life -.58 (<.001)
Physical well-being -.54 (<.001)
Social/family well-being -.27 (.006)
Emotional well-being -.40 (<.001)
Functional well-being -.46 (<.001)
Table 4.
Influencing Factors on Quality of Life
Variables B SE β t p Tolerance VIF
(Constant) 89.16 3.46   25.79 <.001    
Distress -12.35 2.11 -.48 -5.86 <.001 .97 1.03
Type of treatment -7.54 2.10 -.29 -3.59 .001 .97 1.03
      Adj.R2=0.35, F=28.08, p<.001    

CCRT= Concurrent chemotherapy and radiation therapy; Dummy variables: distress (≥4= 1,<4= 0); Type of treatment (CCRT= 1, Planned surgery= 0).

TOOLS
Similar articles